XIFIN Named a 12-Time Inc. 5000 Honoree a Testament to Company’s Crucial Support of Healthcare Diagnostics

Inc. has just published its 5,000 fastest-growing private companies in America list for 2021, and XIFIN is among its ranks for the 12th time in its 24-year history. During a period of unprecedented challenges for the healthcare industry and a significant shift towards telehealth, XIFIN proved able to not only meet the technological demands of diagnostic providers facing enormous testing volume...

Read


Delta Variant Impact on Lab Testing Volumes

The impact of the SARS-CoV-2 Delta variant is increasingly severe. The CDC has determined this strain is nearly twice as contagious as previous variants and two studies indicate Delta patients are more likely to be hospitalized than those infected with Alpha or the original virus strains.1 97.4% of all U.S. COVID-19 cases stem from this variant.2Infection numbers are rising rapidly. On August 11...

Read


Telehealth Is Here to Stay

One of the lasting changes born of the pandemic is the expectation by healthcare providers that they will continue to leverage telehealth and remote patient monitoring platforms in their practices. According to the “COVID 19 Telehealth Impact Study” conducted by the COVID 19 Healthcare Coalition, in 2018 only 18% of physicians incorporated telehealth as part of their care model, primarily due to...

Read


Pathology Denial Metrics and Implementing a Strategic Appeals Processes

Pathology practices are becoming increasingly inundated with added requirements for prior authorization and medical necessity documentation. Insurance requirements are becoming more onerous, and lines are increasingly blurred around what is required for claims to meet individual payor standards for reimbursement. Failure to meet a single requirement, on even a small percentage of claims, is...

Read


The Value of Highly Flexible Client/Physician e-Invoicing Capabilities

There are several scenarios in which ordering entities, such as physician practices, want other healthcare providers, like laboratories or medical device companies, to bill them for services performed or devices delivered rather than billing payors or patients. For example, if a diagnostic provider offers only non-covered services, such as a new genetic test or novel medical device, the ordering...

Read


Hospital Price Transparency: Does it Change Your Outreach Lab Program Strategy?

Recently, I had the great privilege to participate in a Healthcare Financial Management Association (HFMA) virtual panel discussion on compliance with hospital price transparency requirements. One of the primary topics I covered during the discussion was how technology can help reduce the “lift” for hospital outreach laboratories to achieve and maintain compliance with the new rule, which became...

Read


Things to Consider When Building a Patient and Provider Engagement Infrastructure

This blog post is the final installment of our three part series. View Part One and Part Two. On the recent Fierce Healthcare webinar, “Billing and Patient Access Tools to Boost Digital Health Profit,” I had the pleasure of addressing patient and provider engagement tools.The fact is, healthcare billing and claims processing — more specifically the revenue cycle management (RCM) process for...

Read


Q3 Industry Updates – News You Can Use

Welcome to a round up of relevant news that piqued my interest over the past 60 days: Select Aetna Updates  Aetna announced that effective September 1, 2021, it will no longer pay for professional services performed in a hospital setting for technical-only procedure codes. The CMS Physician Fee Schedule lists these codes as diagnostic only. They do not have a related professional code. Note: This...

Read